128 related articles for article (PubMed ID: 38401583)
1. Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson's disease via mitochondrial dysfunctions.
Peng Y; Wang C; Ma W; Chen Q; Xu G; Kong Y; Ma L; Ding W; Zhang W
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130347. PubMed ID: 38401583
[TBL] [Abstract][Full Text] [Related]
2. Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
Zhang W; Liu J; Chen Q; Ding W; Li S; Ma L
Neurochem Res; 2022 Nov; 47(11):3355-3368. PubMed ID: 35962937
[TBL] [Abstract][Full Text] [Related]
3. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
[TBL] [Abstract][Full Text] [Related]
4. GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Berois N; Gattolliat CH; Barrios E; Capandeguy L; Douc-Rasy S; Valteau-Couanet D; Bénard J; Osinaga E
Clin Chem; 2013 Jan; 59(1):225-33. PubMed ID: 23136245
[TBL] [Abstract][Full Text] [Related]
5. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
6. Role of microtubule-associated protein 6 glycosylated with Gal-(β-1,3)-GalNAc in Parkinson's disease.
Ma L; Song J; Sun X; Ding W; Fan K; Qi M; Xu Y; Zhang W
Aging (Albany NY); 2019 Jul; 11(13):4597-4610. PubMed ID: 31289257
[TBL] [Abstract][Full Text] [Related]
7. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
[TBL] [Abstract][Full Text] [Related]
8. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
10. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
Seo MH; Yeo S
Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
[TBL] [Abstract][Full Text] [Related]
11. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions.
Hanisch FG; Müller S; Hassan H; Clausen H; Zachara N; Gooley AA; Paulsen H; Alving K; Peter-Katalinic J
J Biol Chem; 1999 Apr; 274(15):9946-54. PubMed ID: 10187769
[TBL] [Abstract][Full Text] [Related]
12. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of
Cejas RB; Lorenz V; Garay YC; Irazoqui FJ
J Biol Chem; 2019 Mar; 294(9):2997-3011. PubMed ID: 30591584
[TBL] [Abstract][Full Text] [Related]
14. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl-transferase from the snail Biomphalaria glabrata - substrate specificity and preference of glycosylation sites.
Taus C; Windwarder M; Altmann F; Grabherr R; Staudacher E
Glycoconj J; 2014 Dec; 31(9):661-70. PubMed ID: 25338825
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of Andrographolide against Neurotoxin MPP
Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873
[TBL] [Abstract][Full Text] [Related]
16. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
[TBL] [Abstract][Full Text] [Related]
17. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
18. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
20. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
